Published in J Vet Intern Med on April 09, 2003
A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma. BMC Vet Res (2016) 1.38
Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry. Anal Chem (2009) 1.21
Comparative oncology today. Vet Clin North Am Small Anim Pract (2007) 1.09
Productive replication of human adenovirus type 5 in canine cells. J Virol (2005) 0.97
Domestic dogs and cancer research: a breed-based genomics approach. ILAR J (2014) 0.93
Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther (2014) 0.92
Canine urothelial carcinoma: genomically aberrant and comparatively relevant. Chromosome Res (2015) 0.85
Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo. Cancer Prev Res (Phila) (2013) 0.85
Bacterial urinary tract infections associated with transitional cell carcinoma in dogs. J Vet Intern Med (2015) 0.84
Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand. Mol Cancer (2011) 0.82
Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Int J Nanomedicine (2012) 0.81
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development. J Urol (2011) 0.80
Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs. J Vet Intern Med (2015) 0.78
Epidermal growth factor receptor expression in canine transitional cell carcinoma. J Vet Med Sci (2014) 0.77
The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. BMC Vet Res (2014) 0.77
A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine. Anal Biochem (2014) 0.77
Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines. BMC Cancer (2014) 0.77
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro. Drug Des Devel Ther (2015) 0.76
Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma. PLoS One (2016) 0.76
Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma. BMC Vet Res (2017) 0.75
Metastatic transitional cell carcinoma in proximal humerus of a dog. Can Vet J (2011) 0.75
Clinical experience of MRI in two dogs with muscle-invasive transitional cell carcinoma of the urinary bladder. J Vet Med Sci (2016) 0.75
Chemotherapy and radiation therapy in 4 dogs with muscle-invasive transitional cell carcinoma of the urinary tract. Can Vet J (2012) 0.75
A cultured approach to canine urothelial carcinoma: molecular characterization of five cell lines. Canine Genet Epidemiol (2015) 0.75
Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs. J Vet Intern Med (2015) 0.75
Transitional cell carcinoma of the urinary bladder in a 14-year-old dog. Can Vet J (2011) 0.75
Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: a report of 10 cases (2005-2011). Can Vet J (2015) 0.75
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer. Drug Des Devel Ther (2016) 0.75
Total cysto-prostatectomy: Technique description and results in 2 dogs. Can Vet J (2016) 0.75
Urethral Stenting for Obstructive Uropathy Utilizing Digital Radiography for Guidance: Feasibility and Clinical Outcome in 26 Dogs. J Vet Intern Med (2017) 0.75
Primary fibrosarcoma of the urinary bladder in a cat: follow-up after incomplete surgical excision. JFMS Open Rep (2017) 0.75
NMR-based metabolomics study of canine bladder cancer. Biochim Biophys Acta (2012) 1.59
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1. Cancer Gene Ther (2004) 1.49
Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum (2002) 1.30
Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res (2006) 1.24
Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry. Anal Chem (2009) 1.21
Cancer prevention interdisciplinary education program at Purdue University: overview and preliminary results. J Cancer Educ (2011) 1.11
Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008). J Am Vet Med Assoc (2011) 1.11
Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs. J Am Vet Med Assoc (2002) 1.09
Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc (2004) 1.08
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther (2006) 1.05
Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res (2002) 1.02
Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med (2003) 0.99
Canine anal sac adenocarcinomas: clinical presentation and response to therapy. J Vet Intern Med (2002) 0.99
A preliminary study of intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI. J Neurotrauma (2004) 0.98
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Urol Oncol (2008) 0.97
Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J (2014) 0.96
Accuracy of three-dimensional and two-dimensional ultrasonography for measurement of tumor volume in dogs with transitional cell carcinoma of the urinary bladder. Am J Vet Res (2012) 0.94
Targeting folate receptors to treat invasive urinary bladder cancer. Cancer Res (2012) 0.92
Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects. Mol Cancer Ther (2006) 0.91
Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder. Mol Cancer Ther (2010) 0.91
Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. J Am Vet Med Assoc (2004) 0.91
Outcome of urethral stent placement for management of urethral obstruction secondary to transitional cell carcinoma in dogs: 19 cases (2007-2010). J Am Vet Med Assoc (2012) 0.88
Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma. J Am Anim Hosp Assoc (2005) 0.87
Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc (2005) 0.87
Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc (2011) 0.86
Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Mol Cancer Ther (2008) 0.85
Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma. J Am Vet Med Assoc (2013) 0.84
Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol Cancer Ther (2003) 0.84
In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles. J Control Release (2012) 0.82
DNMT1: an emerging target in the treatment of invasive urinary bladder cancer. Urol Oncol (2012) 0.82
Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc (2007) 0.82
Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc (2002) 0.80
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development. J Urol (2011) 0.80
Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010). J Am Vet Med Assoc (2013) 0.80
Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment. Prostaglandins Leukot Essent Fatty Acids (2007) 0.79
Usefulness of a half-fourier acquisition single-shot turbo spin-echo pulse sequence in identifying arachnoid diverticula in dogs. Vet Radiol Ultrasound (2012) 0.79
Expression and purification of the intact cytoplasmic domain of the human ephrin receptor A2 tyrosine kinase in Escherichia coli. Protein Expr Purif (2005) 0.79
Detection of synovial macrophages in the joint capsule of dogs with naturally occurring rupture of the cranial cruciate ligament. Am J Vet Res (2005) 0.78
Appearance of common ultrasound artifacts in conventional vs. spatial compound imaging. Vet Radiol Ultrasound (2010) 0.78
Lightning injury in an outdoor swine herd. J Vet Diagn Invest (2003) 0.77
RUNX3 methylation and the potential to predict the behavior of bladder cancer. J Urol (2008) 0.77
Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer. Adv Exp Med Biol (2002) 0.76
Ultrasound-guided endoscopic diode laser ablation in dogs with transitional cell carcinoma. J Am Vet Med Assoc (2012) 0.75
Topical flea and tick pesticides and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc (2004) 0.75
Assessment of folate receptor expression and folate uptake in multicentric lymphomas in dogs. Am J Vet Res (2014) 0.75
Effects of cyclooxygenase inhibitor treatment on the renal toxicity of cisplatin in rats. Cancer Chemother Pharmacol (2009) 0.75
What Is Your Diagnosis? J Am Vet Med Assoc (2017) 0.75
What is your diagnosis? Two well-circumscribed, mineralized opacities in the left caudal quadrant of the abdomen. J Am Vet Med Assoc (2002) 0.75